Fractional CFO Services Focused Exclusively on Life Science Companies
BioMed Financial is a Miami based consulting firm dedicated to the Life Sciences sector — including Medical Devices, Diagnostics, Pharma, Specialty Pharma, Biotech, Digital Health, and SaMD.
We partner with early to clinical stage companies to provide investor ready financial strategy, operational guidance and executive-level insight — without the overhead of a full-time CFO.
Services
Aligning your financial roadmap to your valuation inflection milestones
Fractional CFO
Our fractional CFO service provides senior level financial leadership without the overhead of a full-time hire. We help shape financial strategy, prepare board level reports, manage investor relations and guide senior leadership through critical financial decisions with hands on expertise.
Strategic Financial Advisory
We deliver strategic advisory services that include capital planning, valuation modeling, investor readiness, and fundraising support. Our team ensures that your company has a clear financial roadmap and the right strategies in place to execute and drive long-term growth.
Partnering & Exits
We help you navigate complex financial transactions. We assist with partner selection, modeling various deal structures, negotiation of LOI’s and Term Sheets, guidance during due diligence, and help structuring financial terms that maximize opportunities for shareholder return.
Back Office
We provide comprehensive back-office support to ensure accuracy, compliance, and scalability. From bookkeeping, accounts receivable/payable, and payroll to implementing robust financial control and reporting systems, we help streamline operations so your team can focus on growth.
Insights
Strategic insights on life sciences finance, capital strategy, and growth.

Cost to Bring an ADC to IND

Understanding the financial roadmap and capital requirements for early-stage ADC development.

Read More

Economics of Dialysis Access Centers

A breakdown of reimbursement, margins, and operational strategy in vascular access.

Read More

Reducing Biotech Development Risk

Key financial and operational strategies to de-risk early-stage life science companies.

Read More
Contact Us